SYNERA Drug Patent Profile

✉ Email this page to a colleague

When do Synera patents expire, and what generic alternatives are available?

Synera is a drug marketed by Galen Specialty and is included in one NDA.

The generic ingredient in SYNERA is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SYNERA?
What are the global sales for SYNERA?
What is Average Wholesale Price for SYNERA?

Summary for SYNERA

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	4
Clinical Trials:	21
Patent Applications:	1
Drug Prices:	Drug price information for SYNERA
What excipients (inactive ingredients) are in SYNERA?	SYNERA excipients list
DailyMed Link:	SYNERA at DailyMed

Drug patent expirations by year for SYNERA

Recent Clinical Trials for SYNERA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Boston Children's Hospital	N/A
Linde AG	N/A
Boston Children’s Hospital	N/A

See all SYNERA clinical trials

US Patents and Regulatory Information for SYNERA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for SYNERA

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005	⤷ Sign Up	⤷ Sign Up
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005	⤷ Sign Up	⤷ Sign Up
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005	⤷ Sign Up	⤷ Sign Up
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005	⤷ Sign Up	⤷ Sign Up
Galen Specialty	SYNERA	lidocaine; tetracaine	PATCH;TOPICAL	021623-001	Jun 23, 2005	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for SYNERA

See the table below for patents covering SYNERA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	6076200		⤷ Sign Up
Canada	2375655		⤷ Sign Up
Canada	2345494	PROCEDE ET APPAREIL D'ADMINISTRATION DE FENTANYL ET DE SUFFENTANIL (METHODS AND APPARATUS FOR IMPROVED ADMINISTRATION OF FENTANYL AND SUFENTANIL)	⤷ Sign Up
European Patent Office	1117357	DISPOSITIFS SERVANT À AMELIORER L'ADMINISTRATION DE COMPOSES ACTIFS SUR LE PLAN PHARMACEUTIQUE (APPARATUS FOR IMPROVED ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	03024383		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for SYNERA

Recent Clinical Trials for SYNERA

Make Better Decisions: Try a trial or see plans & pricing